[1]
Y. K. Opoku, “Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells”, EXCLI J., vol. 19, pp. 567–581, May 2020.